NEW: The largest study ever of deceased male ice hockey players by @bu_cte found that the odds of having CTE increased by 34% each year played, and 18 of 19 NHL players studied had CTE. https://t.co/aWIfZ9bt0s
After a high dose of psilocybin, the brain desynchronizes at a massive scale, causing loss of our sense of self, time, and space. This may drive the burst of plasticity caused by psychedelics. The next day, brain activity has largely returned to normal, but an echo remains – a reset of circuits critical to the sense of self.
Our study is out today in @Nature https://t.co/PjACA6nkAy
Warren Buffett on valuations today…
“I don’t think anyone at this table has any idea of how to use it [$189B in cash] effectively, and therefore we don’t use it. We only swing at pitches we like… today things aren’t attractive. We’re not using it at 5.4%, but I wouldn’t use it at 1% either. But don’t tell the Federal Reserve that.
I don’t mind at all, given current conditions, building our cash position. When I look at the equity markets and the composition of what’s going on in the world, we find cash quite attractive.”
@NonGaap@RecoveringBank2 No comment on the deal as I haven’t looked at it in the slightest… but ScienceIO did raise another ~$15m last year…
I had heard ~$4-50 ‘24 rev range. No clue re current run rate and/or the val for that round.
Today we’re sharing the full presentation for anyone to read - including:
📈 lessons from the public markets
🎛️ macro uncertainty and what to watch
🛣 founders building for efficiency + scale
Full presentation on our website ➡️ https://t.co/skSTYcwDA5 3/3
Why did $ILMN split-out and then re-acquire Grail?
Shareholders need to consider the possibility ILMN insiders sequenced the split-off and $10B buyout to accumulate a material, undisclosed Grail position that later produced a $500m to $1B+ finc'l windfall
https://t.co/36XWnh0LPC
I described some of the most beautiful and famous mathematical theorems to Midjourney.
Here is how it imagined them:
1. "The set of real numbers is uncountably infinite."
@Biotech2k1 The main takeaway I’ve heard… it’s an exciting new approach - like first reactions to CRISPR etc over the years
Outside of that… another signal hotspot / dna-only dx is in the past.. MRNA buying an onc dx co ft broad database wouldn’t surprise me